Our present study explored VPA's neuroprotective propensities in the MPP+-induced PD model in primary cultured dopamine (DA) neurons and focused on the role of VPA in the GSK3β-activated mitochondrial apoptosis pathway by using PI3K and MAPK pathway-specific inhibitors. The gene discussed is GSK3B; the disease is Parkinson disease.